advertisement
 

  Back to Polls Poll Results

Poll Results

 

Which insulins do you or your child use?

 
 

Vote for all that apply

 
 

Short acting insulins

 
     

NovoLog/Novorapid

 
 

27%

 

  238

 
     

Humalog

 
 

22%

 

  195

 
     

Regular/Actrapid/Velosulin

 
 

1%

 

  14

 
     

Apidra

 
 

1%

 

  2

 
     

Other short acting insulin

 
 

1%

 

  1

 
 

Long acting insulins

 
     

Lantus

 
 

27%

 

  244

 
     

Levemir

 
 

1%

 

  4

 
     

NPH/Isophane/Insulatard

 
 

14%

 

  127

 
     

Lente

 
 

1%

 

  10

 
     

Ultralente

 
 

1%

 

  7

 
     

Other long acting insulin

 
 

1%

 

  10

 
 

Other

 
     

Premixed (70/30, etc.)

 
 

1%

 

  13

 
     

Other insulin

 
 

1%

 

  7

 
     

Don't use insulin

 
 

1%

 

  2

 


Total votes: 930

 

Which insulins do you or your child use?

Poll dates: January 9 - 16, 2005
Total Votes: 874

Insulin users today have a great variety of products from which to choose. In the past few years, two fast-acting analogs (NovoLog and Humalog) and one long-acting analog (Lantus) have been introduced and have changed the way many people use insulin. The use of Regular insulin among our readers has dropped off to just one percent. NPH use has dropped too, from 32% in 2000 to 14% in 2005.

This table shows readers' answers to this survey over the past four years:

  Answer     Jan 2005     Jan 2004     Jan 2003     Jan 2002     Mar 2000  
Short acting insulins
NovoLog 27% 26% 12% 3% --
Humalog 22% 26% 34% 37% 35%
Regular 1% 2% 3% 4% 12%
Apidra 1% -- -- -- --
Long acting insulins
Lantus 27% 21% 17% 11% --
Levemir 1% -- -- -- --
NPH 14% 16% 22% 28% 32%
Lente 1% 1% 1% 3% 4%
Ultralente 1% 1% 2% 5% 7%
Other
Premixed 1% 1% 2% 2% 5%
Other insulin 1% 1% 2% 2% 2%
Percentages based on use compared with all responses

Looking at answers in the short-acting and long-acting insulins shows a dramatic change since 2000. The following graphs illustrate the rapid increase in use of insulin analogs and the concurrent decline in the use of Regular and NPH.

Rapid Acting Insulin Use

The rise in the use of NovoLog has been particularly significant since it was introduced in 2002. Among users of rapid-acting insulin, NovoLog is used by more than half of our visitors (53%), while use of Humalog continues to decline and is now at 43%. The use of Regular has declined to one percent of CWD visitors.

Graph. Click for larger view.
Data within rapid-acting insulin only

Graph. Click for larger view.
Data among all responses

Long Acting Insulin Use

Throughout 2004 and into 2005, the use of Lantus continued to increase among CWD visitors who report using long acting insulin. This year, almost two-thirds (62%) of people who use long acting insulin report using Lantus. The use of NPH dropped 20% in the past year and now stands at 32%. Few people use Lente and Ultralente. New this year is Levemir, but it is not yet available in the US.

Graph. Click for larger view.
Data within long-acting insulin only

Graph. Click for larger view.
Data among all responses

[Download an Excel spreadsheet with the data and graphs from this poll]

[Return to the current poll]



                 
  Home Return to Top

Last Updated: Wednesday March 16, 2005 16:38:02
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.